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Abstract 
The use of contrast enhanced magnetic resonance imaging (MRI) for the detection of orthopedic pathologies in equine 
patients is poorly described. In few studies, enhanced MRI allowed to differentiate active lesions from chronic ones 
and to classify ambiguous lesions. The aim of this clinical prospective pilot study is to describe and compare the MRI 
lesions observed  in horses with lameness localized to the foot using a single intravenous bolus dose of gadolinium 
contrast versus regional intraarterial bolus of contrast agent. Ten horses that underwent contrast enhanced MRI were 
included in the study. Gadolinium was injected intravenously in 3 patients and in 7 horses contrast agent was 
administered by intraarterial regional delivery. Regions of interest (ROI) were collected from both pre- and post-
contrast images and ratios between pre- and post-contrast ROIs were calculated. No adverse reactions were noted after 
contrast agent injection. Injured structures that revealed greater increase in signal in post-contrast images were the 
deep digital flexor tendon (DDFT), the navicular spongiosa and the peritendinous tissues. Regional intraarterial 
administration of gadolinium provided higher ratio of contrast enhancement. Enhanced MRI using both intravenous 
or intraarterial injection of gadolinium, increased the diagnostic capability of MRI in horses with foot lesions. 
Nevertheless, regional intraarterial administration of gadolinium was considered the best choice due to the higher 
signal and lower volumes of contrast agent required.  
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Introduction 
Magnetic resonance imaging (MRI) is widely used in 
the diagnosis of orthopaedic disease in horses. As a 
consequence of the high sensitivity of MRI in detection 
of changes within soft tissues, understanding which 
lesions are involved in the current clinical process may 
be difficult (Judy et al., 2010; Severaid and Judy, 
2012). Some signal alterations have been described on 
both sound and lame horses (Dyson and Murray, 2007; 
Murray et al., 2007; Holowinsky et al., 2010). 
Holowinsky et al. (2010) observed that resolution of 
tendons and ligaments lesions on STIR images was 
related to an improvement of the lameness. Otherwise, 
when bone marrow lesions were present, there was no 
correlation between clinical signs and resolution of 
lesions in STIR sequences (Holowinsky et al., 2010). 
Furthermore, some subtle lesions can be overlooked or 
underestimated, especially using low field system 
(Dyson et al., 2010; Judy et al., 2010).  
To avoid underestimation, overlooking and to evaluate 
the dynamic status of an injury, in humans contrast 
enhanced MRI has been performed since the early 
1990s (Beltran et al., 1991; Sofka and Potter, 2001; 
Schmid et al., 2002; Hodgson et al., 2012; Gärdin et al., 
2013; Ntoulia et al., 2013; Tavares et al., 2014). Eshed 
et al. (2015) demonstrated that un-enhanced MRI using 
STIR sequences was only moderately reliable for 
synovitis assessment when contrast enhanced MRI was 
considered the gold standard. 
There are only few reports describing the use of 
contrast enhanced MRI (Ferrell et al., 2002; Judy et al., 
2010; Severaid and Judy, 2012; De Zani et al., 2013; 
Nelson et al., 2017; Aarsvold et al., 2018) in horses 
while the use of contrast medium is well reported in 
computed tomography (CT) (Puchalski et al., 2007, 
2009; Puchalski, 2012; Vallance et al., 2012; Van 
Hamel et al., 2014; Carmalt and Montgomery, 2015; 
Nelson et al., 2017).  
The high capability of enhanced CT and MRI in soft 
tissue lesion detection has been proved but the 
administration of an appropriate systemic dose of 
intravenous contrast agent is not practical due to the 
large volume required. To significantly reduce the 
contrast agent dose and injection time, regional 
intraarterial administration contrast agent has been used 
in CT studies of the equine distal limb and head, and a 
small but statistically significant increase in attenuation 
of soft tissue was observed (Puchalski et al., 2007; 
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Carmalt and Montgmomery, 2015). Aarsvold et al. 
(2018), described the use of enhanced MRI following 
regional limb perfusion in horses, after contrast 
medium administration via a palmar/plantar digital 
vein. Authors proved that contrast enhanced MRI 
increased the detection of lesions, especially of the 
collateral sesamoidean and impar ligament. 
To the authors knowledge, intraarterial injection of 
contrast agent for MRI in the equine patient has never 
been described, while in human medicine it was used in 
pediatric patients or in patients with sensitivity to 
iodinated-contrast agent to avoid problems related to 
iodinate toxicity (Arat et al., 2000; Spinosa et al., 2002; 
Zeller et al., 2002; Burry et al., 2004).  
The aim of this study is to describe the effectiveness of 
enhanced MRI in equine patients with lameness 
localized to the foot region using a single intravenous 
bolus dose of gadolinium contrast versus regional 
intraarterial bolus of contrast agent and comparing the 
contrast enhancement obtained using the systemic 
injection versus the loco-regional administration of 
contrast agent. 
Materials and Methods 
Selection and Description of Subjects 
The study was a clinical prospective pilot study. Ten 
horses with unilateral lameness localized to the foot 
region were included in the study, which was conducted 
between January 2014 and December 2014. Owners 
were consulted prior inclusion in the study and written 
and verbal consent was obtained. A complete physical 
examination, complete blood count and survey 
radiographs of both front feet were obtained. 
Ten horses were included in the study. Horses were of 
different breed, the mean age was 10.5 years (range 
between 1 and 16 years); there were 2 stallions, 6 
geldings and 2 mares. Six right forelimbs, 3 left 
forelimbs and one right hind limb were evaluated using 
contrast enhanced MRI.  
Three horses were included in Group 1 and received the 
contrast agent injection into the right jugular vein. 
Seven horses were included in Group 2 and the contrast 
agent was administered in the radial artery (6 horses) or 
in the dorsal metatarsal artery (1 horse). 
Horses were premedicated with intravenous xylazine 
(1,1 mg/kg) (Nerfasin, A.T.I. s.r.l., Ozzano Emilia, 
Italy), and acepromazine (0.03 mg/kg) (Prequillan, 
Fatro S.p.A., Ozzano Emilia, Italy), and anesthesia was 
induced using a combination of ketamine (2.2 mg/kg) 
(Ketavet 100, Intervet Productions, Peschiera 
Borromeo, Italy), and diazepam (0.05 mg/kg) (Valium, 
Roche, Basel, Switzerland). 
Anesthesia was maintained with isoflorane (Isoflurane-
Vet, Merial Italia S.p.A., Milano, Italy) in oxygen. The 
horses were positioned on a custom made MRI 
compatible table on left lateral recumbency. Magnetic 
resonance images were acquired using a low-field 
magnet (0.18 T) (MR-Vet; Esaote, Genova, Italy) and 
a knee-receiving coil. The acquisition protocol included 
sagittal and transverse three-dimensional T1-weighted 
gradient echo sequences (T3DT1), sagittal and dorsal 
short τ inversion recovery sequences (STIR) and 
transverse dual echo sequences (ME). Images were 
obtained using a 1 mm slice thickness for the T3DT1 
sequences and a 4 mm slice thickness with a 0.4 mm 
gap for all other sequences. After contrast agent, 
gadodiamide (Omniscan, GE Healthcare S.r.l., Milano, 
Italy) injection, T3DT1 sequences in three different 
orthogonal planes were acquired. Contrast agent was 
administered using two different protocols:  systemic 
intravenous injection (Group 1) and intraarterial 
regional delivery (Group 2). Each horse was assigned 
randomly to Group 1 or Group 2. Systemic intravenous 
injection was performed using a 14 G catheter in the 
right jugular vein and 0.1 ml/kg of contrast agent was 
injected. The intraarterial regional injection was 
performed using a 20 G catheter placed in the radial 
artery. A tourniquet was placed just distal to the carpal 
or tarsal joint  and 0.02 ml/kg of contrast agent were 
administered. Post-contrast sequences were acquired 
immediately after contrast medium injection. 
Ethical considerations 
Animals included in the study underwent to 
radiographic and magnetic resonance examination for 
clinical investigation following the good veterinary 
practice and after obtaining informed client consent. 
Data recording and Analysis 
Using a dedicated DICOM software (OsiriX; Pixmeo 
SARL, Geneve, Switzerland) MD, Regions Of Interest 
(ROI) pixel intensity of specific area were collected 
from both pre- and post-contrast images. Measurements 
were retrospectively assessed by a single observer. The 
ROIs included four predefined regions and four areas 
with abnormal findings (Table 1). In order to evaluate 
the value of contrast enhancement ratios between pre- 
and post-contrast ROIs were calculated dividing the 
difference between the post-contrast ROI value and the 
pre-contrast ROI value by the pre-contrast ROI value.  
Statistics 
A paired t-test was used to determine if the signal 
intensity of the post-contrast ROI obtained with the two 
different contrast agent administration protocols was 
significantly different from the pre-contrast ROI of 
both the prearranged normal regions of interest and the 
pathological regions of interest. Significance was set at 
p<0.05. An unpaired t-test was used to evaluate the 
statistical significance of contrast enhancement ratio 
obtained comparing the systemic intravenous injection 
of contrast agent and regional intraarterial delivery of 
gadolinium. Significance was set at p<0.05. 
Intraobserver agreement was determined using all 
measurements that were assessed by the same observer 
twice within 4 weeks.  
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Table 1. Localization of the points used for the ROI of both normal (Predefined) and abnormal regions.  
 
Intraobsever agreement indices (AI) were calculated 
and the means were obtained. An AI of 1 indicated 
perfect agreement, an AI of ≥0.9 indicated excellent 
agreement. For all the statistical analysis a specific 
software was used (SAS; SAS Institute Inc., Cary, 
North Carolina, USA). 
Results 
Horses were monitored during the MRI examination 
and for the following 48 hours. No adverse reaction or 
side effects were observed during and after the injection 
procedure and vital parameters were within the normal 
range. Total duration of anesthesia ranged between 60 
and 70 minutes. 
The radial and dorsal metatarsal arteries were identified 
by palpation and the placement of the catheter was 
easily carried-out in all horses without US guidance. 
Ratio values of contrast enhancement in normal and 
pathological regions after intravenous bolus of contrast 
agent were summarized in table 2. Ratio values of 
contrast enhancement after intraarterial regional 
injection were summarized in table 3.  
The normal structures of the prearranged regions that 
showed greatest contrast enhancement after 
intravenous bolus were the medial palmar digital artery 
and vein, the dorsal aspect of the coffin joint capsule 
and the dorsal cortical bone of the middle phalanx. The 
deep digital flexor tendon was noted to have a 
significant enhancement only when pathological (Point 
5: p= 0.05 and Point 6: p=0.011).  
Pathological areas different from DDFT showed a mild 
enhancement, in absence of statistical significance 
(p=0.146).  
After intraarterial regional injection of contrast agent, 
normal regions that showed a greater enhancement 
were the same observed after intravenous bolus 
administration. In the areas of the deep digital flexor 
tendon (Point 6 and Point 7) and in the navicular bone 
spongiosa /peritendinous tissues, a high enhancement 
was noted, reaching statistical significance in both deep 
digital flexor tendon (Point 5: p=0.02 and Point 6: 
p=0.05) and in the navicular spongiosa/peritendineous 
tissues (p=0.04). 
The means of ratios values achieved from the two 
methods of contrast agent administration were 
compared and the difference of the contrast 
enhancement obtained from the techniques was noted 
to be of statistical significance (p=0.01) (Fig. 1). 
Alterations of the DDFT were the most frequent: four 
lesions were observed in the region proximal to 
navicular bone, 2 at level of the navicular bone and 6 in 
the region proximal to DDFT insertion. In 8 horses a 
distal impar sesamoidean ligament (DSIL) desmopathy 
was detected and adhesions between DSIL and DDFT 
were recognized. In two of 8 horses DSIL injuries were 
observed only on post-contrast images. No 
involvement of the peritendinous tissues was noted on 
pre-contrast T1W and on STIR sequences while in 
post-contrast images it was observed in 3 cases. 
Enhanced MRI highlighted the presence of presumed 
scar tissue in 4 horses. On STIR sequences, eight of the 
twelve lesions involving the DDFT were visible; in two 
cases, adhesion between DDFT and DSIL were poorly 
recognizable on fat suppressed images while in 8 horses 
no alteration of DSIL was detected.  
Point ROI location Predefined Region 
Pathological Region 
Alterations detected 
1 
Medial palmar digital artery and vein, 1 cm 
proximal to the navicular bone 
Normal structure- 
Predefined region 
 
2 Dorsal aspect of the Coffin Joint 
Normal structure-  
Predefined  region 
 
3 Deep Digital Flexor Tendon 
Normal structure-  
Predefined  region 
 
4 
Middle third of the dorsal cortex of the intermediate 
phalanx 
Normal structure-  
Predefined  region 
 
5 
Deep Digital Flexor 
Tendon 
Region proximal to 
navicular bone 
 
Tears, core lesions, dorsal 
abrasion, sagittal and 
parasagittal split 
6 
Deep Digital Flexor 
Tendon 
Region at level of navicular 
bone 
 
Tears, core lesions, dorsal 
abrasion, sagittal and 
parasagittal split 
7 
Deep Digital Flexor 
Tendon 
Region proximal to DDFT 
insertion 
 
Tears, core lesions, dorsal 
abrasion, sagittal and 
parasagittal split 
8 
Distal Sesamoidean Impar Ligament (DSIL), 
Navicular Bone Spongiosa, Peritendinous tissue, 
Navicular Bone Flexor Cortex 
 
DSIL desmitis, Bone Marrow 
Lesion, Erosion of the Flexor 
Cortex, peritendinous 
edema/inflammatory reaction 
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Table 2. Results of the ratio values obtained after intravenous injection of gadolinium.  
 
 
Table 3. Results of the ratio values obtained after intraarterial injection of gadolinium. 
 
Case 
Group 2: Ratio values after intra-arterial regional injection of contrast medium Dose of contrast 
agent (0.02 ml/kg) Point 1 Point 2 Point 3 Point 4 Point 5 Point 6 Point 7 Point 8 
1 0.718 0.089 0.384 0 0.123 0.511 0.172 0.370 14 ml 
2 0.171 1.442 0.287 4.38 0.622 1.384 2.257 1.811 12 ml 
3 2.998 2.432 0.432 1.288 0.616 0.736 0.793 0.370 10 ml 
4 0.376 2.09 0.320 0.665 0.490 0.246 0.235 0.645 8 ml 
5 0.377 1.621 0.228 0 0.116 0.8 1.343 0.460 10 ml 
6 0.879 0.218 0.070 0 1.29 0.623 0.412 0.394 11 ml 
7 0.663 2.364 0.392 0 0.126 1.605 0.539 0.795 9 ml 
Mean 
(SD) 
0.883 
(0.96) 
1.465 
(0.97) 
0.302 
(0.12) 
0.905 
(1.61) 
0.483 
(0.42) 
0.844 
(0.48) 
0.822 
(0.75) 
0.692 
(0.52) 
 
p < 0.05 
t=2.5 
p=0.0465 
t=3.6 
p=0.0114 
t=5.39 
p=0.0017 
t=1.93 
p=0.102 
t=2.96 
p=0.0253 
t=2.442 
p=0.0503 
t=1.79 
p=0.112 
t=2.50 
p=0.0465 
 
 
In one case, an erosion of the flexor cortex of the 
navicular bone was observed in both pre-contrast T1W 
and STIR sequences, showing an intense enhancement 
after contrast agent injection. 
Discussion 
In this pilot study we described the effectiveness of 
enhanced MRI in equine patients with lameness 
localized to the foot using a single intravenous bolus 
dose of gadolinium contrast versus regional 
intraarterial bolus of contrast agent and comparing the 
contrast enhancement obtained using the systemic 
injection versus the loco-regional administration of 
contrast agent. In all non-pathological predefined 
regions the high enhancement was observed in the 
medial palmar digital artery and vein, the dorsal aspect 
of the coffin joint capsule and the dorsal cortical bone 
of the middle phalanx but statistical significance was 
reached only after intraarterial regional contrast agent 
injection (Fig. 1). The lack of statistical significance 
after intravenous administration was in contrast with 
data reported previously by Judy et al. (2010) and can 
be explained by the small sample size used in this 
prospective pilot study. The deep digital flexor tendon 
did not show enhancement in normal condition, as 
described in other studies (Judy et al., 2010); in fact, 
tenoligamentous structures were poorly vascularized in 
absence of active lesions or angiogenic process.  
 
Fig. 1. The graphic shows the comparison between the mean 
ratios in the 8 ROI point after intravenous  and intraarterial 
administration of contrast agent. The value of standard 
deviation (SD) are shown in brackets. 
 
The high value of enhancement ratio observed at level 
of the dorsal cortical bone of the intermediate phalanx 
had to be considered as an artifact due to partial volume 
averaging (Pozzi Mucelli et al., 2008). A statistically 
significant difference between pre-contrast and post-
contrast ROIs was noted when DDFT (Fig. 2 and Fig. 
3) and DSIL were involved in pathological processes. 
The increase in value of post-contrast ROIs was more 
significant after intraarterial regional injection of 
contrast agent. In accordance with previously observed, 
it was possible to affirm that the use of contrast agent 
can implement the diagnostic capability of MRI in 
detection of tenoligamentous injuries.  
Case 
Group 1: Ratio values after intravenous bolus of contrast medium Dose of contrast 
agent (0.1 ml/kg) Point 1 Point 2 Point 3 Point 4 Point 5 Point 6 Point 7 Point 8 
1 0.649 0.552 0.012 1.442 0.575 0.680 0.187 0.578 30 ml 
2 0.256 0.413 -0.337 0 0.235 0.198 0.261 0.194 60 ml 
3 0.752 0.830 0.220 0 0.857 0.464 0.159 0.694 50 ml 
Mean 
(SD) 
0.552 
(0.26) 
0.598 
(0.21) 
-0.035 
(0.28) 
0.481 
(0.83) 
0.556 
(0.31) 
0.447 
(0.24) 
0.202 
(0.05) 
0.489 
(0.26) 
 
p < 0.05 
t=3.7 
p=0.066 
t=3.08 
p=0.091 
t=1.54 
p=0.26 
t=1.64 
p=0.24 
t=4.09 
p=0.055 
t=9.32 
p=0.011 
t=3.55 
p=0.071 
t=2.32 
p=0.146 
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Fig. 2. Transverse pre- (A) and post-contrast after intraarterial 
regional administration (B) T1 weighted images (Point 7). In 
the pre-contrast image multiple DDFT parasagittal split 
lesions are visible in both tendon lobes. In the post-contrast 
image (B), note the enhancement of the tendon lesions (black 
open arrow) and of the palmar peritendinous tissues (black 
arrow). 
 
 
Fig. 3. Transverse pre- (A) and post-contrast after intravenous 
administration (B) T1 weighted images (Point 8). Enhanced 
image (B) shows an increase in signal in the navicular bone 
cortex and a parasagittal split of a DDFT lobe (white arrow). 
 
The capability to enhance soft tissue injuries was 
strictly related to intrinsic characteristics of 
paramagnetic agent, as gadolinium, to selectively 
diffuse from vessels to extracellular/interstitial space. 
The diffusion from blood to extracellular/interstitial 
space became evident with the presence of injuries, due 
to an increase in capillary permeability, wall 
discontinuity of vascular endothelium, 
neonagiogenesis and granulation tissue formation 
(Movin et al., 1998; Puchalski et al., 2007; Severaid 
and Judy, 2012; Nelson et al., 2017). Otherwise, in 
absence of lesions and tissue damage, the contrast agent 
remained in the vessels without enhancement. As 
speculated by Judy et al. (2010), post-contrast 
sequences could allow to discriminate between active 
and chronic lesions (Nelson et al., 2017). In the present 
study, the presence of neoformed, fibrous-cicatricial 
enhancing tissue was observed in four horses. The 
intense tissue enhancement was considered suggestive 
of active lesions. During the healing process of a 
tenoligamentous structure, different phases 
characterized by changes in tissue vascularization and 
variation in the interstitial matrix can be observed 
(Movin et al., 1998; Shalabi et al., 2002; Shalabi, 2004; 
Sharma and Maffulli, 2005; Puchalsky et al., 2007; 
Severaid and Judy, 2012). In the present study, a large 
number of DDFT lesions were noted. Usually, this type 
of lesion, characterized by an abnormal alignment and 
a cross linking of collagen fibers, appeares 
hyperintense on T1-weighted images, both in acute and 
chronic cases. Based on T1-weighted images, a 
correlation between the signal intensity of a lesion and 
a specific phase of the healing is not possible (Judy et 
al., 2008; Holowinsky et al., 2010; Vanel et al., 2012). 
In clinical practice, understanding of the DDFT lesions 
evolution is mandatory to obtain prognostic 
information and plan a proper rehabilitation program. 
Enhancement of a lesion after contrast agent 
administration could be an aid for discrimination 
between chronic injuries and lesions of clinical 
relevance. In some studies, authors (Holowinsky et al., 
2010; Vanel et al., 2012) observed that resolution of 
tendon injuries on STIR was associated with improved 
lameness, suggesting that lesions visible on STIR 
images actively contribute to lameness.  
Furthermore, lesions involving DSIL can be 
underestimated, especially using a low-field MRI (Judy 
et al., 2008). In our study, post-contrast sequences 
allowed visualization of DSIL injuries (two feet) and 
peritendinous soft tissue increased signal (Fig. 1) (4 
feet), that were missed in non enhanced images. Some 
authors (Schramme et al., 2009; McGill et al., 2015) 
observed that saline bursography or saline arthrography 
of the distal interphalangeal joint can improve the 
visualization of the podotrochlear apparatus with low-
field MRI. Both techniques had some disadvantages; 
saline bursography prolongs duration of general 
anesthesia and increases the risk of bursa ruptures, 
while saline arthrography of the distal interphalangeal 
joint can be performed only in non-weight bearing 
horses and it is not feasible during standing MRI 
examination (McGill et al., 2015). On the other hand, 
gadolinium enhanced MRI can either be performed in 
standing patient and, in patient under general 
anesthesia, without a substantial increase of general 
anesthesia time. 
In the present study two different ways of gadolinium 
administration have been used and compared, the 
intravenous (Judy et al., 2008; Severaid and Judy, 
2012; De Zani et al., 2013) and the intraarterial 
injection. In veterinary medicine, intraarterial injection 
of contrast agent has been used with Computed 
Tomography (Puchalski et al., 2007, 2009; Carmalt and 
Montgomery, 2015), but there are no publications that 
describe the use of locoregional intraarterial contrast 
administration. Also in humans, intraarterial injection 
of gadolinium is also poorly discussed and its use is 
reported mainly in angiographic studies (Boos et al., 
1998; Burry et al., 2004).  
In our preliminary data, a more intense enhancement 
was observed after locoregional intraarterial contrast 
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injection, in both pathologic and non-pathologic 
regions. The difference between contrast enhancement 
was statistically significant; nevertheless, further study 
with a large number of samples are mandatory. Indeed 
locoregional intraarterial injection allowed a major 
concentration of gadolinium by-passing the systemic 
circulation and directly reaching the region of interest.  
Another advantage of regional intraarterial 
administration is the low dose of contrast agent 
required; the gadolinium dose usually reported for 
intravenous injection is 0.1-0.2 ml/kg body weight, 
while, in the present study we used for the intraarterial 
administration, a dose of 0.02 ml/kg body weight, 
dramatically reducing the total dosage and volume of 
contrast agent.  
Even if the gadolinium-based contrast media have been 
associated with different types of toxicity, further 
studies are mandatory before drawing conclusion on the 
clinical implications of gadolinium accumulation in 
human and animal tissues (Ramalho et al., 2016; 
Pasquini et al., 2018). For these reasons, a potential 
toxicity must be seriously considered in all patients. On 
the basis of the published data, a reduction of the total 
dose must be achieved in order to decrease the risk of 
toxicity, especially in patients with renal impairment or 
renal failure (Ramalho et al., 2016). Furthermore, low 
dose of contrast agent can decrease the cost of contrast 
enhanced MR examination.  
In the present study no adverse reactions or side effects 
have been observed in horses after contrast agent 
administration.  In a previous study, Saveraid and Judy 
(2012) noted a mild and transient decrease in blood 
pressure after gadolinium injection when horses were 
in dorsal recumbency. In our study, no changes in blood 
pressure was observed, probably due to the different 
recumbency in which horses were positioned. 
Arterial catheterization was performed at the level of 
the radial artery, without ultrasonographic guidance. 
The radial artery was chosen instead of the medial 
palmar artery because of its superficial localization that 
makes it easily digitally palpated (Puchalski et al., 
2007; Spriet et al., 2015). In hind limb, the catheter was 
inserted into the dorsal metatarsal artery as for invasive 
blood pressure monitoring (Gent et al., 2015). In human 
medicine, ultrasound guidance for artery 
catheterization was preferred to traditional palpation 
because of higher first-attempt success rate and reduced 
incidence of hematoma (Tang et al., 2014). 
Nevertheless, in veterinary medicine there is no 
evidence to prefer one technique over another.  
This was a clinical prospective pilot study and therefore 
the sample was small and unequal between the two 
groups. The small sample size precluded us from 
performing meaningful statistics. Another limitation is 
the lack of histology examination of the lesions and 
confirmation of the findings observed on MRI images. 
In conclusion, contrast enhanced MRI should be 
considered as a useful tool for detection of 
tenoligamentous lesions in the equine patient that could 
provide information about staging of disease. On the 
basis of preliminary data, locoregional intraarterial 
administration via the radial artery is more valuable that 
intravenous injection due to its higher contrast 
enhancement using lower dose of gadolinium.  
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